AMENDMENT NO. 2 TO REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 11th, 2021 • AgeX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amendment No. 2, dated as of February 10, 2021 (the “Amendment”), is entered into by and between AgeX Therapeutics, Inc., a California corporation (the “Company”) and Juvenescence, Limited, a company incorporated in the Isle of Man (the “Holder”). Capitalized terms used in this Amendment and not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement (as defined below).
DATED: February 10, 2021 AGEX THERAPEUTICS INC. (as Borrower) - and - JUVENESCENCE, LIMITED (as Lender) AMENDMENT NO. 1 TO LOAN FACILITY AGREEMENTLoan Facility Agreement • February 11th, 2021 • AgeX Therapeutics, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 1, made as of February 10, 2021 (this “Amendment”), TO THE LOAN FACILITY AGREEMENT, dated as of August 13, 2019 (the “Original Loan Agreement” and, as amended hereby, the “Loan Agreement”)
